LiverUnit_VallHebron (@LHuvh) header
LiverUnit_VallHebron (@LHuvh) profile picture

Your liver, our problem, your solutions. Fighting all liver diseases with enthusiasm and talent. This is not an institutional account.

Barcelona
Joined June 2018
Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)Photo by LiverUnit_VallHebron (@LHuvh)
🟠 La #AEEH avala el 2º 'Barcelona International Workshop on Clinical Trials in MASH cACLD/cirrhosis' 👥El 26 de mayo, este encuentro científico de alto nivel reunirá en Barcelona a líderes internacionales en hepatología para debatir sobre selección de pacientes, endpoints y nuevas terapias en #MASH y #cirrosis. Entre ellos, nuestro presidente Rafael Bañares o expertos como @mromerogomez @JuanAbraldes @pericas_jm @docberza o @AleksanderKrag. 🧑‍💻 Inscripción gratis aquí:🔗vallhebron.com/en/node/30869
10
10
617
And dinner of the Spanish Portal Hypertension (Fraternity) Group 👏👏👏🔝🔝🔝 @AEEH2026 @AEEHLiver @BavenoCoop @CIBER_ISCIII @VHIR_
1
1
7
576
Many fantastic scientific activity from members of our @LHuvh during the #AEEH2026 Congratulations to the team 👏👏👏 @AEEHLiver @CIBER_ISCIII @VHIR_
3
196
LiverUnit_VallHebron retweeted
💡 The ANTICIPATE-NASH models outperform histology in predicting clinical events in advanced MASLD, enabling better patient risk stratification for clinical care and trial selection. Read the full study here: ow.ly/27TO50Y7EO7 🖋️ @JuanAbraldes
11
26
2,367
Delayed but not forgotten, celebrating ending the residence with our @LHuvh senior residents in hepatology. Some will stay, some will go away, but remembered will be all. @vallhebron @VHIR_ @AEEHLiver
3
244
The 25 kPa for #CSPH is valid, buy the #ANTICIPATE+/- NASH 75% is better. A new ruling in criterion for CSPH by the @BavenoCoop: Refining the Baveno VII criteria for clinically significant portal hypertension- Journal of Hepatology journal-of-hepatology.eu/art… @LHuvh @VHIR_ @ciberehd
7
21
1,796
LiverUnit_VallHebron retweeted
Original Article Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death Vutien et al. #LiverX tinyurl.com/4v7r4cev
3
18
1
49
4,474
LiverUnit_VallHebron retweeted
Ciao Jaume, goodbye cariño mio. You have been such a special and wonderful man and I will love you forever.
35
23
1
215
12,632
The Liver Unit @LHuvh of HUVH @vallhebron wants to pay tribute to Jaime Bosch. A model for hepatologists and a true friend . The portal hypertension gang @BavenoCoop is now orphan.
With deep sadness, we share the passing of Dr. Jaime Bosch — a visionary researcher, passionate physician, and cherished friend. Widely regarded as the father of portal hypertension, the Liver Unit of Barcelona will always be indebted to his immense legacy.
10
546
New research - Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial thelancet.com/journals/langa… #LiverTwitter #MedTwitter
3
53
2
105
11,522
Mar Riveiro @mar_riveiro from our @LHuvh preventing a multi center study on CDKi-induced liver injury
2
188
Annalisa @docberza presenting our rule of 5 from our @LHuvh in the clinical state of the art at #EASL2025
11
28
1,913
Juanma Pericàs from our @LHuvh presenting today in a MASLD therapy session at #EASLCongress
1
16
761
LiverUnit_VallHebron retweeted
📊 Validation of Baveno VII criteria for non-invasive diagnosis of clinically significant portal hypertension: systematic review and individual patient data meta-analysis #POSTER WED-512-YI by Juan Bañares (@vallhebron) #EASL2025 @ef_clif @easlnews
5
16
1,058